Nasopharyngitis, headache, elevated blood insulin, diarrhea, injection-site erythema, pharyngitis, arthralgia, injection-site reaction, fatigue, rash, nausea, anemia, mucositis, neutropenia, respiratory distress, lung infections and sepsis. This evidence concerns the gene INS and neutropenia.